CLL cell proliferation induced by TLR agonists after 6 days was impaired by ND2158 treatment and no difference between MYD88-mutated and -unmutated cases was observed (Fig. 3c). The gene discussed is MYD88; the disease is B-cell chronic lymphocytic leukemia.